NTRANS TECHNOLOGIES
NTrans Technologies offers a proprietary platform technology for the intracellular delivery of bioactive molecules. The company is further developing this technology for both research and clinical purposes as a method for the delivery of biologicals that is safe, non-toxic, highly efficient, and easy to use. NTrans Technologies' goal is to be a leader in technologies for the transduction of proteins and other bioactive molecules into primary cells.
NTRANS TECHNOLOGIES
Industry:
Biotechnology Product Research Wellness
Founded:
2015-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.ntranstechnologies.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0)644448450
Email Addresses:
[email protected]
Total Funding:
1.51 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Venture Round - NTrans Technologies
Official Site Inspections
http://www.ntranstechnologies.com
- Host name: web0133.zxcs.nl
- IP address: 185.104.29.102
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "NTrans Technologies"
NTrans Technologies – We deliver…
The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy. We have developed a game-changing, modular delivery platform, designed …See details»
About us – NTrans Technologies
At NTrans, we are moved by a pioneering spirit and a deep commitment to transforming medicine. We prioritize excellence and innovation in our daily endeavors, so that we can make a positive …See details»
NTrans Technologies - Crunchbase Company Profile
View contacts for NTrans Technologies to access new leads and connect with decision-makers. NTrans Technologies offers a proprietary platform …See details»
Our platform – NTrans Technologies
Our primary focus is on improving how we deliver CRISPR/Cas technology to cells for ex vivo therapies, targeting breakthroughs in immuno-oncology (CAR-T and TCR therapies) and …See details»
NTrans Technologies BV - LinkedIn
At NTrans Technologies, we solve key challenges in cell and gene therapy: Delivering life-changing therapies to the right cells and tissues. We leverage nature’s own mechanisms for …See details»
Ntrans Technologies Company Profile 2024: Valuation, …
Operator of a biotech company intended to develop a proprietary platform for the intracellular delivery of bioactive molecules.See details»
NTrans Technologies - Craft
See insights on NTrans Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
NTRANS TECHNOLOGIES BV - VentureRadar
Website: http://www.ntranstechnologies.com/ NTrans Technologies BV was founded in 2015 based on a proprietary platform technology for the intracellular delivery of bioactive molecules …See details»
NTrans Technologies BV - Drug pipelines, Patents, Clinical trials
Oct 24, 2024 · Explore NTrans Technologies BV with its drug pipeline, therapeutic area, technology platform, .See details»
NTrans Technologies BV | Leiden Bio Science Park - lbsp.nl
Housing over 215 organisations, including 150 Life Sciences & Health (LSH) companies – from start-ups to multinationals – and several internationally acclaimed research institutes, the …See details»
Ester Weijers new CEO NTrans – NTrans Technologies
Apr 10, 2024 · New CEO joins NTrans Technologies, Ester Weijers, PhD. “At NTrans Technologies, we embrace the power of science and technology to uplift lives. As CEO, I am …See details»
NTrans Technologies BV Overview | SignalHire Company Profile
NTrans Technologies BV has been founded in 2015 as a spin-off from the Hubrecht Institute (KNAW) by Prof. Niels Geijsen (Co-inventor), and Dr. Marco de Boer. NTrans Technologies …See details»
NTrans Technologies - Company Profile - Tracxn
Nov 18, 2024 · What does NTrans Technologies do? NTrans Technologies uses a platform iTOP, developed by Hubrecht Institute of the Royal Netherlands Academy of Sciences for delivery of …See details»
NTrans Technologies - Products, Competitors, Financials, …
NTrans Technologies specializes in non-viral delivery platforms for cell and gene therapy within the biotechnology sector. The company offers a modular delivery platform that enhances the …See details»
NTrans Technologies - Mibiton
NTrans Technologies (NTrans) is developing a gene-editing therapy for the muscle disease Duchenne (DMD). The patented therapeutic platform activates a cell's natural uptake …See details»
Contact – NTrans Technologies
Join us in developing breakthrough therapies for cancer and genetic disorders.See details»
NTrans Technologies Stock Price, Funding, Valuation, Revenue ...
Jun 3, 2021 · See NTrans Technologies funding rounds, investors, investments, exits and more. Evaluate their financials based on NTrans Technologies's post-money valuation and revenue.See details»
Working at NTrans Technologies - Glassdoor
See what employees say it's like to work at NTrans Technologies. Salaries, reviews, and more - all posted by employees working at NTrans Technologies.See details»
SonarScanner for Maven - SonarSource
The SonarScanner for Maven is recommended as the default scanner for Maven projects. The ability to execute the SonarQube analysis via a regular Maven goal makes it available …See details»
News – NTrans Technologies
We are excited to share that EUR 10 million has been awarded to NecstGen, NTrans… Launch of the new branding and website. Health Holland non-dilutive funding awarded. NTrans joins the …See details»